We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Supplementary data for the 2023 TB regional and devolved reports.
Annual regional reports for the epidemiology of TB in 2023.
England annual data on coverage achieved by the childhood immunisation programme.
Use of intravenous immunoglobulin for the treatment of invasive PVL-SA infection in hospital inpatients.
Occurrence of venous thromboembolism in hospital inpatients with invasive PVL-SA infections.
Effectiveness of decolonisation regimes to prevent recurring or secondary infection with Staphylococcal skin and soft tissue infections.
This rapid evidence gap map identifies and categorises the available evidence on Oropouche virus to inform research prioritisation.
Reports on travel-associated infections in England, Wales and Northern Ireland, based on data from national reference laboratories or case management systems.
Annual reports on voluntary surveillance of fungaemia (blood infections due to yeast species) in England.
Routine reports on confirmed cases of non-foodborne zoonoses reported in England.
The number of infections of Escherichia coli (E. coli) O157 reported in England and Wales for 2019 and 2020, and England only from 2021 onwards.
Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of chikungunya vaccines in UK travellers.
Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programmes for autumn 2026 and spring 2027.
Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes not in Prevenar 13™ vaccine.
Cumulative weekly data on invasive pneumococcal disease (IPD) infections due to serotypes in Prevenar 13™ in England.
Update to end of December 2024 on enhanced surveillance of potentially iatrogenic CJD exposures -- occasional reports related to human prion disease surveys.
Annual data from 2008 onwards for England.
Annual data of reported Campylobacter infections in England since 2006.
Qualitative assessment of the risk that West Nile virus presents to the UK population.
The epidemiological and clinical characteristics of Argentine haemorrhagic fever.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).